TIZANIDINE
- Product NDC
- 80175-0169
- 11-digit product format
- 801750169
- Labeler code
- 80175
- Product ID
- 80175-0169_be252d0e-629f-7552-e053-2a95a90ac117
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Central Packaging
- Application
- ANDA091283
- Marketing category
- ANDA
- Marketing start
- 2013-04-01
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 80175-0169-3 | TIZANIDINE | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 80175-0169-6 | TIZANIDINE | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
| 80175-0169-9 | TIZANIDINE | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 80175-0169 | TIZANIDINE TABLET [CENTRAL PACKAGING] | 1 | Legacy NDC, 3 package rows | 20210220_bba33f22-bd11-3149-e053-2a95a90a8585.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 80175-0169-3 | 80175016903 | 30 TABLET in 1 BOTTLE (80175-0169-3) | 30 tablet | 2013-04-01 | 0000-00-00 | No | No | Current |
| 80175-0169-6 | 80175016906 | 60 TABLET in 1 BOTTLE (80175-0169-6) | 60 tablet | 2013-04-01 | 0000-00-00 | No | No | Current |
| 80175-0169-9 | 80175016909 | 90 TABLET in 1 BOTTLE (80175-0169-9) | 90 tablet | 2013-04-01 | 0000-00-00 | No | No | Current |